1. Home
  2. ROG vs SPRY Comparison

ROG vs SPRY Comparison

Compare ROG & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROG
  • SPRY
  • Stock Information
  • Founded
  • ROG 1832
  • SPRY 2015
  • Country
  • ROG United States
  • SPRY United States
  • Employees
  • ROG N/A
  • SPRY N/A
  • Industry
  • ROG Industrial Machinery/Components
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROG Technology
  • SPRY Health Care
  • Exchange
  • ROG Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • ROG 1.9B
  • SPRY 1.6B
  • IPO Year
  • ROG N/A
  • SPRY N/A
  • Fundamental
  • Price
  • ROG $103.59
  • SPRY $14.01
  • Analyst Decision
  • ROG
  • SPRY Strong Buy
  • Analyst Count
  • ROG 0
  • SPRY 4
  • Target Price
  • ROG N/A
  • SPRY $24.00
  • AVG Volume (30 Days)
  • ROG 148.4K
  • SPRY 1.3M
  • Earning Date
  • ROG 10-24-2024
  • SPRY 11-13-2024
  • Dividend Yield
  • ROG N/A
  • SPRY N/A
  • EPS Growth
  • ROG N/A
  • SPRY N/A
  • EPS
  • ROG 2.67
  • SPRY N/A
  • Revenue
  • ROG $842,500,000.00
  • SPRY $2,568,000.00
  • Revenue This Year
  • ROG N/A
  • SPRY $21,686.67
  • Revenue Next Year
  • ROG $3.60
  • SPRY $956.61
  • P/E Ratio
  • ROG $38.77
  • SPRY N/A
  • Revenue Growth
  • ROG N/A
  • SPRY 8460.00
  • 52 Week Low
  • ROG $96.10
  • SPRY $4.53
  • 52 Week High
  • ROG $138.85
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • ROG 49.94
  • SPRY 41.90
  • Support Level
  • ROG $101.63
  • SPRY $13.80
  • Resistance Level
  • ROG $114.05
  • SPRY $18.51
  • Average True Range (ATR)
  • ROG 3.17
  • SPRY 1.23
  • MACD
  • ROG -0.02
  • SPRY -0.24
  • Stochastic Oscillator
  • ROG 36.99
  • SPRY 12.62

About ROG Rogers Corporation

Rogers Corporation designs develop and manufacture engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: advanced connectivity solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and power electronics solutions, which sells ceramic substrate materials for power module applications. The firm generates revenue in the United States, China, and Germany, but has a presence around the world.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: